Windtree Therapeutics (WINT)
NASDAQ:WINT
US Market
Holding WINT?
Track your performance easily

Windtree Therapeutics (WINT) Cash flow

179 Followers

Windtree Therapeutics Cash Flow

WINT's free cash flow for Q4 2023 was $-2.95M. For the 2023 fiscal year, WINT's free cash flow was decreased by $4.69M and operating cash flow was $-2.95M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -12.82M$ -19.45M$ -23.66M$ -25.32M$ -24.66M$ -15.78M
Investing Cash Flow
$ -15.00K$ 197.00K$ -279.00K$ -291.00K$ 13.80M$ -13.73M
Financing Cash Flow
$ 12.11M$ 3.08M$ 29.36M$ 19.96M$ 21.77M$ 38.74M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 26.18M$ 6.33M$ 22.50M$ 17.08M$ 22.73M$ 11.36M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
-----$ 288.00K
Issuance Of Capital Stock
$ 1.37M$ 4.25M$ 4.84M$ 20.25M$ 22.98M$ 32.89M
Issuance Of Debt
$ -796.00K$ -1.17M$ -3.87M$ 547.00K$ 1.00M$ 7.66M
Repayment Of Debt
$ -718.00K$ -1.17M$ -3.87M$ -3.78M$ -2.06M$ -1.66M
Free Cash Flow
$ -9.34M$ -19.25M$ -23.94M$ -25.61M$ -24.85M$ -15.78M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Windtree Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis